EE200300468A - Pravastatiini stabiilne farmatseutiline kompositsioon - Google Patents
Pravastatiini stabiilne farmatseutiline kompositsioonInfo
- Publication number
- EE200300468A EE200300468A EEP200300468A EEP200300468A EE200300468A EE 200300468 A EE200300468 A EE 200300468A EE P200300468 A EEP200300468 A EE P200300468A EE P200300468 A EEP200300468 A EE P200300468A EE 200300468 A EE200300468 A EE 200300468A
- Authority
- EE
- Estonia
- Prior art keywords
- pravastatin
- pharmaceutical composition
- stable pharmaceutical
- stable
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN375DE2001 | 2001-03-27 | ||
PCT/IB2002/000882 WO2002076376A2 (en) | 2001-03-27 | 2002-03-22 | A stable pharmaceutical composition of pravastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300468A true EE200300468A (et) | 2004-02-16 |
Family
ID=29560486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300468A EE200300468A (et) | 2001-03-27 | 2002-03-22 | Pravastatiini stabiilne farmatseutiline kompositsioon |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040157925A1 (es) |
EP (1) | EP1372616A4 (es) |
JP (1) | JP2004527518A (es) |
KR (1) | KR20030096294A (es) |
CN (1) | CN1240377C (es) |
BR (1) | BR0208504A (es) |
CA (1) | CA2442280A1 (es) |
CZ (1) | CZ20032828A3 (es) |
EE (1) | EE200300468A (es) |
HU (1) | HUP0401234A2 (es) |
MX (1) | MXPA03008837A (es) |
NZ (1) | NZ528543A (es) |
PL (1) | PL369268A1 (es) |
RU (1) | RU2003131338A (es) |
SK (1) | SK13022003A3 (es) |
WO (1) | WO2002076376A2 (es) |
ZA (1) | ZA200308256B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003055217A (ja) * | 2001-08-10 | 2003-02-26 | Taiyo Yakuhin Kogyo Kk | 医薬組成物 |
CA2465693A1 (en) * | 2003-06-12 | 2004-12-12 | Warner-Lambert Company Llc | Pharmaceutical compositions of atorvastatin |
ES2342885T3 (es) * | 2003-08-06 | 2010-07-16 | Galephar M/F | Composiciones farmaceuticas de liberacion controlada estables que contienen fenofibrato y pravastatina. |
WO2006008757A2 (en) * | 2004-05-05 | 2006-01-26 | Cadila Healthcare Limited | Stabilized pharmaceutical compositions of pravastatin |
DK2094841T3 (da) * | 2006-12-13 | 2012-05-29 | Dsm Sinochem Pharm Nl Bv | Fremgangsmåde til fremstilling af pravastatin |
CA2691956A1 (en) * | 2007-06-25 | 2008-12-31 | Pharmathen S.A. | Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
GB0713707D0 (en) * | 2007-07-13 | 2007-08-22 | Generics Uk Ltd | Stable compositions |
WO2011049122A1 (ja) * | 2009-10-21 | 2011-04-28 | 第一三共株式会社 | プラバスタチンナトリウム口腔内速崩壊錠及びその製造方法 |
US9399064B2 (en) | 2011-04-12 | 2016-07-26 | Sawai Pharmaceutical Co., Ltd. | Pitavastatin-containing preparation and method for producing same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX7065E (es) * | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
US5225202A (en) * | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
TW474809B (en) * | 1995-07-03 | 2002-02-01 | Sankyo Co | A pharmaceutical composition for arteriosclerosis or xanthoma consisting of HMG-CoA reductase inhibitors and insulin sensitizers |
US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
SI20109A (sl) * | 1998-12-16 | 2000-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Stabilna farmacevtska formulacija |
-
2002
- 2002-03-22 CN CNB028093542A patent/CN1240377C/zh not_active Expired - Fee Related
- 2002-03-22 NZ NZ528543A patent/NZ528543A/en unknown
- 2002-03-22 MX MXPA03008837A patent/MXPA03008837A/es not_active Application Discontinuation
- 2002-03-22 PL PL02369268A patent/PL369268A1/xx not_active Application Discontinuation
- 2002-03-22 SK SK1302-2003A patent/SK13022003A3/sk unknown
- 2002-03-22 EE EEP200300468A patent/EE200300468A/xx unknown
- 2002-03-22 CA CA002442280A patent/CA2442280A1/en not_active Abandoned
- 2002-03-22 BR BR0208504-6A patent/BR0208504A/pt not_active IP Right Cessation
- 2002-03-22 KR KR10-2003-7012675A patent/KR20030096294A/ko not_active Application Discontinuation
- 2002-03-22 CZ CZ20032828A patent/CZ20032828A3/cs unknown
- 2002-03-22 WO PCT/IB2002/000882 patent/WO2002076376A2/en not_active Application Discontinuation
- 2002-03-22 EP EP02716958A patent/EP1372616A4/en not_active Withdrawn
- 2002-03-22 JP JP2002574892A patent/JP2004527518A/ja not_active Withdrawn
- 2002-03-22 RU RU2003131338/15A patent/RU2003131338A/ru not_active Application Discontinuation
- 2002-03-22 HU HU0401234A patent/HUP0401234A2/hu unknown
-
2003
- 2003-10-23 ZA ZA200308256A patent/ZA200308256B/en unknown
-
2004
- 2004-04-12 US US10/473,208 patent/US20040157925A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200308256B (en) | 2004-08-12 |
KR20030096294A (ko) | 2003-12-24 |
WO2002076376A3 (en) | 2003-01-09 |
RU2003131338A (ru) | 2005-02-10 |
SK13022003A3 (sk) | 2004-03-02 |
BR0208504A (pt) | 2004-03-09 |
EP1372616A2 (en) | 2004-01-02 |
CN1518443A (zh) | 2004-08-04 |
CN1240377C (zh) | 2006-02-08 |
NZ528543A (en) | 2005-07-29 |
MXPA03008837A (es) | 2004-05-05 |
PL369268A1 (en) | 2005-04-18 |
EP1372616A4 (en) | 2004-06-23 |
JP2004527518A (ja) | 2004-09-09 |
CA2442280A1 (en) | 2002-10-03 |
HUP0401234A2 (hu) | 2004-11-29 |
US20040157925A1 (en) | 2004-08-12 |
WO2002076376A2 (en) | 2002-10-03 |
CZ20032828A3 (en) | 2004-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20011478A (fi) | Farmaseuttinen koostumus | |
NO20033556L (no) | Farmasöytiske formuleringer | |
NO20033384L (no) | Farmasoytisk formulering | |
ATE296619T1 (de) | Feste orale dosierungsform von simethicon | |
FI20105657A (fi) | Farmaseuttisia koostumuksia | |
AR028204A1 (es) | Composiciones farmaceuticas electrohiladas | |
ITMI20010748A0 (it) | Composizioni farmaceutiche | |
DK1395242T3 (da) | Flydende farmaceutisk sammensætning | |
NO20033785L (no) | Farmasöytisk formulering | |
EE05020B1 (et) | Glburiidi ravimkoostis | |
DK1458377T3 (da) | Farmaceutiske sammensætninger indeholdende tegaserod | |
IS7051A (is) | Lyfjasamsetningar | |
NO20035627D0 (no) | Farmasöytisk formulering | |
FI20022128A0 (fi) | Farmaseuttinen koostumus | |
ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
NO20031095D0 (no) | Farmasöytiske sammensetninger | |
EE200300468A (et) | Pravastatiini stabiilne farmatseutiline kompositsioon | |
EP1404303A4 (en) | STABLE PHARMACEUTICAL COMPOSITIONS BASED ON PRAVASTATIN | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain | |
NO20033073D0 (no) | Farmasöytisk sammensetning inneholdende citalopram | |
DE10107261B4 (de) | Pharmazeutische Zusammensetzung | |
EE200200689A (et) | Ravimkoostised | |
NO20041236L (no) | Farmasoytisk formulering | |
FI5468U1 (fi) | Farmaseuttinen koostumus |